Anzeige
Mehr »
Login
Donnerstag, 13.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Das Vatertagsgeschenk für jeden Spekulanten?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ3D ISIN: GG00BD3FV870 Ticker-Symbol: OK1 
Frankfurt
12.05.21
15:33 Uhr
0,065 Euro
+0,002
+2,38 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
OKYO PHARMA LIMITED Chart 1 Jahr
5-Tage-Chart
OKYO PHARMA LIMITED 5-Tage-Chart

Aktuelle News zur OKYO PHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiOKYO Pharma Limited: Holding(s) in Company-
FrOKYO Pharma Limited: Additional Listing1
05.05.OKYO Pharma Limited: Publication of a Prospectus1
OKYO PHARMA Aktie jetzt für 0€ handeln
28.04.IN BRIEF: Okyo Pharma posts positive data for OK-201 in animal model-
28.04.OKYO Pharma LTD: ("OKYO" or the "Company") - OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain280LONDON and BOSTON, April 28, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory...
► Artikel lesen
28.04.OKYO Pharma Limited: Positive Data in an Animal Model using OK-201-
29.03.OKYO Pharma LTD: OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer205LONDON, March 29, 2021 (GLOBE NEWSWIRE) -- OKYO (LSE: OKYO; OTCQB: EMMLF), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory...
► Artikel lesen
29.03.OKYO Pharma Limited: Appointment of Chief Scientific Officer-
03.03.OKYO Pharma Limited: Issue of Equity-
01.03.OKYO Pharma Limited: Issue of Equity-
01.03.OKYO Pharma LTD: OKYO Pharma Limited ("OKYO" or the "Company") - Issue of Equity173LONDON, March 01, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ("OKYO" or the "Company") today announces that it has issued 250,000 ordinary shares of no par value ("Ordinary Shares"), credited as...
► Artikel lesen
23.02.IN BRIEF: Okyo Pharma Secures Patent For Treating Ocular Pain1
23.02.OKYO Pharma LTD: OKYO Pharma has U.S. Patent Issued Covering its Lipid Conjugated Peptide Analogues for treating Ocular Pain and Inflammation239LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ("OKYO" or the "Company"), a biotechnology company focused on the development of novel drugs to treat inflammatory eye diseases and chronic...
► Artikel lesen
23.02.OKYO Pharma Limited: Patent for treating Ocular Pain and Inflammation1
19.01.IN BRIEF: OKYO Pharma Files Patent Application For Use Of Chemerin-
19.01.OKYO Pharma LTD: OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat "cytokine storm" associated with COVID-19 and ARDS402LONDON and BOSTON, Jan. 19, 2021 (GLOBE NEWSWIRE) -- OKYO (LSE: OKYO; OTCQB: EMMLF), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat...
► Artikel lesen
19.01.OKYO Pharma Limited: Filing patent application for the use of Chemerin2
07.01.OKYO Pharma Limited: Directorate Change-
30.11.20OKYO Pharma Limited: Half-year Report-
25.09.20OKYO Pharma LTD: OKYO Pharma Limited ("OKYO" or the "Company") - Result of the Annual General Meeting276THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM...
► Artikel lesen
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1